SEOUL, South Korea--(BUSINESS WIRE)--The precision medicine and biotechnology company, Macrogen (CEO Kap-Seok Yang, www.macrogen.com) (KOSDAQ: 038290), announced on December 20 that its NGS clinical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback